SHP Wealth Management’s Immunic IMUX Stock Holding History

SHP Wealth Management’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$215	Hold	14	–	–	﹤0.01%	1878
2026 Q1	$155	Buy	14 +9	+180%	+$81	﹤0.01%	1749
2025 Q4	$27	Buy	+5	New	+$37	﹤0.01%	1540

Other funds holding IMUX

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JHC

Jones Hill Capital New York $470M AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

SHP Wealth Management's IMUX Position: Q2 2026 in Review

SHP Wealth Management held its Immunic (IMUX) position steady in Q2 2026 at 14 shares worth $215. The position accounts for ﹤0.01% of the portfolio, ranked #1878.

SHP Wealth Management first reported a position in IMUX in Q4 2025 and has held it in 3 quarters since. 56 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

SHP Wealth Management held 14 shares of Immunic worth $215 as of Q2 2026.
SHP Wealth Management left its Immunic share count unchanged in Q2 2026.
Immunic made up ﹤0.01% of SHP Wealth Management's portfolio in Q2 2026, its #1878 holding.
SHP Wealth Management first reported a position in Immunic in Q4 2025 and has held it in 3 quarters since.
56 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on SHP Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.